Alexandra W. van den Belt‐Dusebout

Author

Also Known As

A W van den Belt-Dusebout, A. W. van den Belt-Dusebout, A.W. Van Den Belt-Dusebout, A.W. van den Belt-Dusebout, Alexandra W van den Belt-Dusebout, Alexandra W. van den Belt-Dusebout, Alexandra W. van den Belt‐Dusebout, Alexandra W. van den Belt–Dusebout

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Oncode Institute Radboud University Nijmegen University Medical Center Groningen Radboud University Medical Center

About

Alexandra W. van den Belt‐Dusebout is an author at The Netherlands Cancer Institute specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	970
2	Public Health	2	2	251
3	Classics	1	1	50
4	Epidemiology	1	1	235
5	Gastroenterology	1	1	98

Alexandra W. van den Belt‐Dusebout

Publications

Citations

H-Index

Page 1

	Year	Citations
Late cardiotoxicity after treatment for Hodgkin lymphoma Berthe M.P. Aleman, Alexandra W. van den Belt‐Dusebout, Marie L. De Bruin, Blood	2006	753
Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease Berthe M.P. Aleman, Alexandra W. van den Belt‐Dusebout, Willem J. Klokman, Journal of Clinical Oncology	2003	710
Risk of endometrial cancer after tamoxifen treatment of breast cancer Flora E. van Leeuwen, Alexandra W. van den Belt‐Dusebout, F.E. van Leeuwen, The Lancet Breast OncologyMedicineGynecologyBreast CancerOncology	1994	571
Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular Cancer Alexandra W. van den Belt‐Dusebout, Ronald de Wit, Jourik A. Gietema, Journal of Clinical Oncology	2007	456
Second cancer risk following Hodgkin's disease: a 20-year follow-up study. Flora E. van Leeuwen, Willem J. Klokman, Anton Hagenbeek, Journal of Clinical Oncology	1994	447
Long-Term Risk of Cardiovascular Disease in 5-Year Survivors of Testicular Cancer Alexandra W. van den Belt‐Dusebout, Janine Nuver, Ronald de Wit, Journal of Clinical Oncology	2006	349
Second cancer risk following testicular cancer: a follow-up study of 1,909 patients. Flora E. van Leeuwen, Anne M. Stiggelbout, Alexandra W. van den Belt‐Dusebout, Journal of Clinical Oncology	1993	252
Roles of Radiotherapy and Smoking in Lung Cancer Following Hodgkin's Disease Flora E. van Leeuwen, Willem J. Klokman, Marilyn Stovall, JNCI Journal of the National Cancer Institute Tobacco ControlEpidemiologyCancer RiskRadiation TherapyMedicine	1995	235
Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. Flora E. van Leeuwen, A.M.J. Chorus, Alexandra W. van den Belt‐Dusebout, Journal of Clinical Oncology	1994	193
Stomach Cancer Risk After Treatment for Hodgkin Lymphoma Lindsay M. Morton, Graça M. Dores, Rochelle E. Curtis, Journal of Clinical Oncology	2013	112

Page 1